Klaria Financial Statements From 2010 to 2025
| KLAR Stock | SEK 1.31 0.01 0.77% |
Check Klaria Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klaria Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Klaria financial statements analysis is a perfect complement when working with Klaria Pharma Valuation or Volatility modules.
Klaria |
Klaria Pharma Holding Company Return On Asset Analysis
Klaria Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Klaria Pharma Return On Asset | -0.29 |
Most of Klaria Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Klaria Pharma Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Klaria Pharma Holding has a Return On Asset of -0.2915. This is 96.67% lower than that of the Healthcare sector and 120.67% lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on asset for all Sweden stocks is 108.21% higher than that of the company.
Klaria Pharma Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Klaria Pharma's current stock value. Our valuation model uses many indicators to compare Klaria Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Klaria Pharma competition to find correlations between indicators driving Klaria Pharma's intrinsic value. More Info.Klaria Pharma Holding is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Klaria Pharma's earnings, one of the primary drivers of an investment's value.About Klaria Pharma Financial Statements
Klaria Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Klaria Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Klaria Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Klaria Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.